Omaha is a clinical research site located in Omaha, Nebraska, United States 68198-4031.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Omaha has participated in 8 clinical trials with 1 currently active.
Therapeutic areas: Clostridium Difficile Infection (CDI), Prostate Cancer, Heavy Menstrual Bleeding.
Sponsors: Rebiotix Inc., Myovant Sciences GmbH, Promontory Therapeutics Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Omaha has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Omaha has 8 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection (CDI), Prostate Cancer, Heavy Menstrual Bleeding.
Omaha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.